R. Caputo

910 total citations
18 papers, 708 citations indexed

About

R. Caputo is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, R. Caputo has authored 18 papers receiving a total of 708 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 5 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in R. Caputo's work include HER2/EGFR in Cancer Research (11 papers), Advanced Breast Cancer Therapies (5 papers) and Cancer Treatment and Pharmacology (5 papers). R. Caputo is often cited by papers focused on HER2/EGFR in Cancer Research (11 papers), Advanced Breast Cancer Therapies (5 papers) and Cancer Treatment and Pharmacology (5 papers). R. Caputo collaborates with scholars based in Italy, United States and Germany. R. Caputo's co-authors include Sabino De Placido, Fortunato Ciardiello, Giampaolo Tortora, G Pomatico, Gabriella Fontanini, John Mendelsohn, Roberto Bianco, V. Damiano, Angelo Raffaele Bianco and Michelino De Laurentiis and has published in prestigious journals such as British Journal of Cancer, Annals of Oncology and Cancer Treatment Reviews.

In The Last Decade

R. Caputo

17 papers receiving 682 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Caputo Italy 9 419 321 196 111 85 18 708
Qingqing Ding United States 10 350 0.8× 406 1.3× 133 0.7× 106 1.0× 77 0.9× 34 732
Jonathan S. Goldberg United States 9 527 1.3× 359 1.1× 597 3.0× 199 1.8× 53 0.6× 11 960
Eva Fernebro Sweden 19 590 1.4× 232 0.7× 203 1.0× 197 1.8× 183 2.2× 28 836
Debashish Bose United States 13 273 0.7× 336 1.0× 269 1.4× 141 1.3× 40 0.5× 17 743
Audrey Rasmussen United States 14 400 1.0× 429 1.3× 113 0.6× 167 1.5× 89 1.0× 18 778
Aikseng Ooi Japan 10 276 0.7× 327 1.0× 210 1.1× 89 0.8× 86 1.0× 18 654
Timothy McDonnell United States 12 406 1.0× 343 1.1× 157 0.8× 219 2.0× 186 2.2× 19 866
Hidemi Kawajiri Japan 15 519 1.2× 253 0.8× 165 0.8× 259 2.3× 139 1.6× 67 857
J. Baselga Spain 10 399 1.0× 312 1.0× 139 0.7× 188 1.7× 44 0.5× 25 649
Jeanie Wu Singapore 13 218 0.5× 552 1.7× 149 0.8× 258 2.3× 108 1.3× 14 904

Countries citing papers authored by R. Caputo

Since Specialization
Citations

This map shows the geographic impact of R. Caputo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Caputo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Caputo more than expected).

Fields of papers citing papers by R. Caputo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Caputo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Caputo. The network helps show where R. Caputo may publish in the future.

Co-authorship network of co-authors of R. Caputo

This figure shows the co-authorship network connecting the top 25 collaborators of R. Caputo. A scholar is included among the top collaborators of R. Caputo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Caputo. R. Caputo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Caputo, R., Michela Piezzo, Claudia von Arx, et al.. (2025). 354P Sacituzumab govitecan for the treatment of metastatic triple-negative breast cancer patients: A multicenter real-world updated analysis. ESMO Open. 10. 104925–104925. 1 indexed citations
2.
Pensabene, Matilde, Alessandra Calabrese, Claudia von Arx, R. Caputo, & Michelino De Laurentiis. (2024). Cancer genetic counselling for hereditary breast cancer in the era of precision oncology. Cancer Treatment Reviews. 125. 102702–102702. 4 indexed citations
3.
Botticelli, Andrea, Simona Pisegna, Simone Scagnoli, et al.. (2023). 236P Trastuzumab deruxtecan in Italian real-world experience: Updated analysis from DE-REAL study. ESMO Open. 8(1). 101424–101424. 2 indexed citations
4.
Botticelli, Andrea, Simone Scagnoli, Simona Pisegna, et al.. (2023). 224P Clinical features and outcomes in HER2+ mBC patients treated with trastuzumab deruxtecan: A subgroup analysis of the De-REAL study. ESMO Open. 8(1). 101413–101413.
5.
Botticelli, Andrea, Simone Scagnoli, Simona Pisegna, et al.. (2022). 267P AB-ITALY: The impact of drug-drug interaction on abemaciclib treatment in Italian real world experience. Annals of Oncology. 33. S659–S660. 2 indexed citations
6.
Lauro, Vincenzo Di, Pietro De Placido, Valeria Forestieri, et al.. (2022). 105P CDK4/6 inhibitors in hormone receptor-positive, HER2-negative, locally advanced breast cancer (LABC): Biological and clinical activity, and post-surgical approaches. Annals of Oncology. 33. S172–S173. 1 indexed citations
7.
Maurea, Nicola, Giovanna Piscopo, Anna Di Rienzo, et al.. (2017). LCZ 696, administered during doxorubicin, trastuzumab or pertuzumab treatment, prevents cardiotoxicity in our in vitro model. Annals of Oncology. 28. v133–v133. 2 indexed citations
8.
Laurentiis, Michelino De, Daniela Cianniello, R. Caputo, et al.. (2010). Treatment of triple negative breast cancer (TNBC): current options and future perspectives. Cancer Treatment Reviews. 36. S80–S86. 146 indexed citations
9.
Gelardi, Teresa, R. Caputo, V. Damiano, et al.. (2008). Enzastaurin inhibits tumours sensitive and resistant to anti-EGFR drugs. British Journal of Cancer. 99(3). 473–480. 18 indexed citations
10.
Tortora, Giampaolo, R. Caputo, Damiano, et al.. (2003). Combined targeted inhibition of Bcl-2, Bcl-xL, EGFR and Protein Kinase A Type I causes potent antitumor, apoptotic and antiangiogenic activity. 866–871. 3 indexed citations
11.
Tortora, Giampaolo, R. Caputo, Roberto Bianco, et al.. (2001). Combined blockade of protein kinase A and bcl-2 by antisense strategy induces apoptosis and inhibits tumor growth and angiogenesis.. PubMed. 7(8). 2537–44. 24 indexed citations
12.
Votolato, Nicholas A., Stephen L. Stern, & R. Caputo. (2000). Serotonergic Antidepressants and Urinary Incontinence. International Urogynecology Journal. 11(6). 386–388. 31 indexed citations
13.
Ciardiello, Fortunato, Roberto Bianco, V. Damiano, et al.. (2000). Antiangiogenic and antitumor activity of anti-epidermal growth factor receptor C225 monoclonal antibody in combination with vascular endothelial growth factor antisense oligonucleotide in human GEO colon cancer cells.. PubMed. 6(9). 3739–47. 321 indexed citations
14.
Tortora, Giampaolo, R. Caputo, G Pomatico, et al.. (1999). Cooperative inhibitory effect of novel mixed backbone oligonucleotide targeting protein kinase A in combination with docetaxel and anti-epidermal growth factor-receptor antibody on human breast cancer cell growth.. PubMed. 5(4). 875–81. 53 indexed citations
15.
Tortora, Giampaolo, R. Caputo, V. Damiano, et al.. (1998). Cooperative Antitumor Effect of Mixed Backbone Oligonucleotides Targeting Protein Kinase A in Combination with Cytotoxic Drugs or Biologic Agents. Antisense and Nucleic Acid Drug Development. 8(2). 141–145. 8 indexed citations
16.
Bianco, Cataldo, Giampaolo Tortora, Gustavo Baldassarre, et al.. (1997). 8-Chloro-cyclic AMP inhibits autocrine and angiogenic growth factor production in human colorectal and breast cancer.. PubMed. 3(3). 439–48. 33 indexed citations
17.
Caputo, R. & J. Thomas Benson. (1992). Idiopathic fecal incontinence. Current Opinion in Obstetrics & Gynecology. 4(4). 565–570. 10 indexed citations
18.
Borrello, Maria Grazia, Emilio Berti, Marco A. Pierotti, et al.. (1989). Clonal immunoglobulin gene rearrangements and normal T-cell receptor, bcl-2, and c-myc genes in primary cutaneous B-cell lymphomas.. PubMed. 49(17). 4901–5. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qingqing Ding Breakdown of academic impact, for papers by Jonathan S. Goldberg Breakdown of academic impact, for papers by Eva Fernebro Breakdown of academic impact, for papers by Debashish Bose Breakdown of academic impact, for papers by Audrey Rasmussen Breakdown of academic impact, for papers by Aikseng Ooi Breakdown of academic impact, for papers by Timothy McDonnell Breakdown of academic impact, for papers by Hidemi Kawajiri Breakdown of academic impact, for papers by J. Baselga Breakdown of academic impact, for papers by Jeanie Wu
Rankless by CCL
2026